LIFECORE BIOMEDICAL, INC. \DE\ LFCR

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $4.35
Market Cap $163.17M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑0.5% YoY
$128.87M
3-Yr CAGR: -11.5%
Net Income ↓-422.3% YoY
-$38.72M
Net Margin: -30.0%
Free Cash Flow ↑26.8% YoY
-$13.62M
FCF Yield: -8.35%
EPS (Diluted) ↓-496.9% YoY
$-1.27
Basic: $-1.27
Return on Equity Efficiency
N/A
ROA: -16.7%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (LFCR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $541.1M $71.0M $-11.6M $-0.43 0.00% $21.8M $-19.1M
FY 2017 $532.3M -1.6% $83.2M $10.6M +191.0% $0.38 +188.4% 0.00% $29.3M $6.7M +135.3%
FY 2018 $524.2M -1.5% $78.3M $24.8M +134.5% $0.89 +134.2% 0.00% $19.8M $-13.8M -305.1%
FY 2019 $557.6M +6.4% $81.0M $0.4M -98.3% $0.01 -98.9% 0.00% $16.0M $-28.7M -107.9%
FY 2020 $590.4M +5.9% $75.0M $-38.2M -9,392.2% $-1.31 -13,200.0% 0.00% $-17.0M $-43.7M -52.3%
FY 2021 $544.2M -7.8% $81.5M $-32.7M +14.5% $-1.12 +14.5% 0.00% $15.0M $-8.8M +80.0%
FY 2022 $185.8M -65.9% $50.4M $-114.7M -251.1% $-3.90 -248.2% 0.00% $-24.4M $-50.6M -478.4%
FY 2023 $103.3M -44.4% $28.0M $-99.6M +13.2% $-3.32 +14.9% 0.00% $-17.4M $-24.4M +51.8%
FY 2024 $128.3M +24.2% $41.9M $12.0M +112.1% $0.32 +109.6% 0.00% $-0.2M $-18.6M +23.7%
FY 2025 $128.9M +0.5% $40.3M $-38.7M -422.3% $-1.27 -496.9% 0.00% $-0.2M $-13.6M +26.8%
$

Valuation

Market Price $4.35
Market Cap $163.17M
Enterprise Value $146.65M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -8.35%
Dividend Yield N/A
Shares Outstanding 37,509,400
%

Profitability & Margins

Gross Margin 31.27%
Operating Margin -13.38%
Net Margin -30.04%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -16.68%
Asset Turnover 0.56x
Revenue 3-Yr CAGR -11.48%
🛡️

Financial Health & Liquidity

Current Ratio 3.49
Cash Ratio 0.74
Debt / Equity -0.067
Debt / Assets 0.004
Cash & Equivalents $17.47M
Total Debt $954.00K
Book Value / Share $-0.38
💧

Cash Flow Efficiency

Operating Cash Flow -$206.00K
Capital Expenditures (CapEx) $13.41M
Free Cash Flow -$13.62M
OCF / Revenue -0.16%
FCF / Revenue -10.57%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.27
EPS (Basic) $-1.27
Dividends / Share N/A
Book Value / Share $-0.38
EPS YoY Growth -496.88%
🏛️

Balance Sheet (FY 2025)

Total Assets $232.18M
Total Liabilities $246.38M
Stockholders' Equity -$14.20M
Current Assets $82.29M
Current Liabilities $23.57M